Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07339891
Recruiting Observational

Experience of Staying in Intensive Care and Impact on Quality of Life

NCT07339891 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Strasbourg, France
Phase
Observational
Started
2025-06-23
Last updated
2026-01-14

Condition(s) studied

Post-traumatic Stress Disorder

Study summary

It now seems well established that post-traumatic stress disorder following a stay in intensive care is one of the factors that affects patients' quality of life after they leave hospital.

Several qualitative and quantitative studies suggest that there are several factors associated with the onset of this post-traumatic stress disorder, including the absence of memory of the stay in intensive care. With this in mind, some intensive care units (in France and abroad) are implementing measures to improve the patient experience during their stay, particularly to compensate for this lack of memory: several studies show a link between the introduction of intensive care unit logbooks and a decrease in the incidence of post-traumatic stress disorder after returning home.

The aim of this research project is to measure the experience of the stay in intensive care and its possible impact on quality of life. It is therefore part of a process of implementing measures within general and cardiovascular surgical intensive care units, aimed at better assessing and improving the quality of life of patients after a stay in intensive care.

Eligibility

Sex
ALL
Min age
18 Months
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult patient (≥ 18 years) * Stay in intensive care \> 48 hours Exclusion Criteria: * Admission to intensive care following scheduled surgery. * Readmission to intensive care (previous admission within the 30 days prior). * Patient under legal guardianship * Inability to complete a questionnaire * Poor reading and/or speaking comprehension of French * Patient under guardianship or conservatorship.

Primary outcome measure(s)

  • ICE questionnaire score — Between 1 and 3 days after discharge from the intensive care unit.
    ICE (Impact Confidence Experience) questionnaire score: The scores for each letter (I, C, E) are added together or averaged. The higher the score, the better. This indicates a positive experience, trust, and a significant impact. Simple example: * Impact = 8/10 → The service was very helpful. * Trust = 9/10 → I trust this team. * Experience = 7/10 → My experience was quite good. Average ICE score = (8 + 9 + 7) ÷ 3 = 8/10
  • Quality of life questionnaire score (SF36) — Day 30 after discharge from hospital
    The SF-36 is a health questionnaire consisting of 36 questions. Each dimension receives a score from 0 to 100: * 100 = very good quality of life * 0 = very poor quality of life

Trial sites (1)

FacilityCityRegionStatus
Service de Réanimation Chirurgicale - CHU de Strasbourg - France Strasbourg France Recruiting

More University Hospital, Strasbourg, France trials in France

Patient-Reported AutoImmunity Secondary to Cancer immunothErapy Active, not recruiting
Personalized Repetitive Transcranial Magnetic Stimulation (rTMS) in Cognitive Fluctuations of Dementia With Lewy Bodies (DLB): Proof of Concept Recruiting
Comparison of the Effect on Anxiety of Combining Hypnosis and Aromatherapy Through Olfactory Anchoring Versus Standard Care in Patients Undergoing Alcohol Withdrawal Starting soon
Evolution of the Cognitive Profile and Quality of Life of Adult Patients Suffering From Severe Migraines Under Preventive Treatment Starting soon
Extracellular Vesicle-based Strategy to Stratify Islets and Improve Their FItness Before Transplantation Starting soon

Other trials for the same condition

A Case Management Algorithm for Women Victims of Violence Recruiting
Predictability of the Clinical Global Impression Scale (CGI) in Post Immediate in Psychotraumatic Impact Recruiting
Qualitative Study on the Perception of Changes in the Psychotherapy of Traumatized Young People Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07339891 on ClinicalTrials.gov ↗ ← All trials in France